Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website

Nektar Therapeutics

Nektar Therapeutics reported $59.88M in Current Liabilities for its fiscal quarter ending in March of 2023.

Current Liabilities Change
Agios Pharmaceuticals AGIO:US USD 45.11M 17.52M
Amgen AMGN:US USD 14.22B 1.47B
Baxter International BAX:US USD 4.76B 15M
Biogen BIIB:US USD 3.01B 257.9M
Bluebird Bio BLUE:US USD 115.93M 12.3M
Cara Therapeutics CARA:US USD 16.68M 6.78M
Eisai 4523:JP JPY 298.94B 14.73B
Eli Lilly LLY:US USD 16.01B 1.13B
Esperion Therapeutics ESPR:US USD 95.49M 3.18M
Exelixis EXEL:US USD 327.6M 3.24M
Gilead Sciences GILD:US USD 10.53B 709M
GlaxoSmithKline GSK:LN GBP 20.7B 2.11B
Halozyme Therapeutics HALO:US USD 91.92M 38.87M
Immunogen IMGN:US USD 101.63M 20.23M
Incyte Corp INCY:US USD 1.01B 150.97M
Ionis Pharmaceuticals IONS:US USD 259.22M 52.34M
Ironwood Pharmaceuticals IRWD:US USD 23.84M 1.68M
Karyopharm Therapeutics KPTI:US USD 61.56M 10.45M
MacroGenics MGNX:US USD 45.61M 3M
Mirati Therapeutics MRTX:US USD 124.6M 34.85M
Nektar Therapeutics NKTR:US USD 59.88M 8.32M
Neurocrine Biosciences NBIX:US USD 374.1M 163.6M
Novartis NOVN:VX USD 30.55B 1.89B
Roche Holding ROG:VX 27.24B 170M
Sarepta Therapeutics SRPT:US USD 536.88M 82.72M
Seattle Genetics SGEN:US USD 713.23M 105.18M
Takeda 4502:JP JPY 2.48T 245.13B
Teva Pharmaceutical Industries Ltd TEVA:IT USD 10.41B 1.06B
Xencor XNCR:US USD 65.06M 1.21M